1. Maternal and neonatal anti-cytomegalovirus IgG level and risk of postnatal cytomegalovirus transmission in preterm infants.
- Author
-
Nijman J, van Loon AM, Krediet TG, and Verboon-Maciolek MA
- Subjects
- Adult, Cytomegalovirus isolation & purification, Cytomegalovirus Infections diagnosis, Female, Humans, Infant, Newborn, Infant, Premature, Male, Pregnancy, Risk Assessment, Urine virology, Young Adult, Antibodies, Viral blood, Cytomegalovirus immunology, Cytomegalovirus Infections transmission, Immunoglobulin G blood, Infectious Disease Transmission, Vertical, Pregnancy Complications, Infectious immunology, Pregnancy Complications, Infectious virology
- Abstract
Immunological mechanisms influencing the risk of mother-to-child cytomegalovirus (CMV) transmission in preterm infants have not been studied sufficiently. In this study, the correlation between maternal and neonatal serum anti-CMV IgG levels and risk of postnatal CMV transmission in preterm infants was assessed. Anti-CMV IgG levels of 79 CMV seropositive mothers and their 94 infants were determined in peripheral blood samples collected within 3 days after delivery. Postnatal CMV infection was detected in 39/94 (41%) infants by PCR on urine at term-equivalent age (gestational age 40 weeks) after congenital infection was excluded. Maternal or infant anti-CMV IgG levels were not significantly different between infants with and without postnatal CMV infection. The anti-CMV IgG infant-mother ratio showed a significant positive correlation with gestational age (range 25-32 weeks, R(2) = 0.218, P < 0.001), reaching 1.0 at 32 weeks of gestation. Anti-CMV IgG infant-mother ratio was significantly lower in infants with postnatal CMV infection (P = 0.015). In conclusion, the risk of postnatal CMV transmission is related to low gestational age and low anti-CMV IgG infant-mother ratio., (Copyright © 2013 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF